Sydney Lupkin

Some are stockpiling the compounded drugs, you know, while they can. I checked in with Mary Struski, an Arizona woman who told me a few weeks ago about how she lost 50 pounds so far on compounded terzepatide. She says she and her nurse practitioner settled on a plan to buy enough terzepatide to get her through until about April.

And after that, she isn't sure, but she says she needs to find a way to keep taking the medicine.

And after that, she isn't sure, but she says she needs to find a way to keep taking the medicine.

And after that, she isn't sure, but she says she needs to find a way to keep taking the medicine.

Her health is better, and she says she's free of the anxiety that came with eating. She's thinking about what she wants to accomplish in 2025.

Her health is better, and she says she's free of the anxiety that came with eating. She's thinking about what she wants to accomplish in 2025.

Her health is better, and she says she's free of the anxiety that came with eating. She's thinking about what she wants to accomplish in 2025.

You know, it could because the FDA just approved ZepBound as the first drug treatment for moderate to severe obstructive sleep apnea in patients who have obesity. Obstructive sleep apnea is a condition in which someone temporarily pauses breathing in their sleep because their upper airway collapses. It is more common among people who have obesity.

You know, it could because the FDA just approved ZepBound as the first drug treatment for moderate to severe obstructive sleep apnea in patients who have obesity. Obstructive sleep apnea is a condition in which someone temporarily pauses breathing in their sleep because their upper airway collapses. It is more common among people who have obesity.

You know, it could because the FDA just approved ZepBound as the first drug treatment for moderate to severe obstructive sleep apnea in patients who have obesity. Obstructive sleep apnea is a condition in which someone temporarily pauses breathing in their sleep because their upper airway collapses. It is more common among people who have obesity.

The new approval could open the door for ZEP-bound coverage by Medicare and Medicaid because it's not just a weight loss drug anymore. So while that's not going to solve everyone's insurance problems here, it could help a lot of people.

The new approval could open the door for ZEP-bound coverage by Medicare and Medicaid because it's not just a weight loss drug anymore. So while that's not going to solve everyone's insurance problems here, it could help a lot of people.

The new approval could open the door for ZEP-bound coverage by Medicare and Medicaid because it's not just a weight loss drug anymore. So while that's not going to solve everyone's insurance problems here, it could help a lot of people.

You bet.

You bet.

You bet.